Synonyms: GS-6615 | GS6615
Compound class:
Synthetic organic
Comment: Eleclazine is a sodium channel inhibitor, modulating cardiac late Na+ currents via the Nav1.5 (gene symbol SCN5A) channel. The compound is a dihydrobenzodiazepine type structure. Dihydrobenzodiazepine scaffolds are being developed as α-helix mimetics, with the potential to inhibit protein-protein interactions [1,3-5]. This chemical structure and its use is covered by patent US20150038489 [2].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one |
International Nonproprietary Names | |
INN number | INN |
9978 | eleclazine |
Synonyms |
GS-6615 | GS6615 |
Database Links | |
CAS Registry No. | 1443211-72-0 |
GtoPdb PubChem SID | 252166623 |
PubChem CID | 71183216 |
Search Google for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | YNUAEEJQYHYLMS |
Search PubMed clinical trials | eleclazine |
Search PubMed titles | eleclazine |
Search PubMed titles/abstracts | eleclazine |
UniChem Compound Search for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |